Sage Therapeutics Inc (SAGE)
13.94
+0.84
(+6.37%)
USD |
NASDAQ |
May 03, 16:00
13.95
+0.01
(+0.07%)
After-Hours: 20:00
Sage Therapeutics Price to Book Value: 1.189 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.189 |
| May 02, 2024 | 1.117 |
| May 01, 2024 | 1.132 |
| April 30, 2024 | 1.189 |
| April 29, 2024 | 1.209 |
| April 26, 2024 | 1.167 |
| April 25, 2024 | 1.158 |
| April 24, 2024 | 1.194 |
| April 23, 2024 | 1.104 |
| April 22, 2024 | 1.099 |
| April 19, 2024 | 1.137 |
| April 18, 2024 | 1.112 |
| April 17, 2024 | 1.072 |
| April 16, 2024 | 1.333 |
| April 15, 2024 | 1.306 |
| April 12, 2024 | 1.316 |
| April 11, 2024 | 1.413 |
| April 10, 2024 | 1.403 |
| April 09, 2024 | 1.409 |
| April 08, 2024 | 1.415 |
| April 05, 2024 | 1.400 |
| April 04, 2024 | 1.414 |
| April 03, 2024 | 1.462 |
| April 02, 2024 | 1.471 |
| April 01, 2024 | 1.526 |
| Date | Value |
|---|---|
| March 31, 2024 | |
| March 28, 2024 | 1.409 |
| March 27, 2024 | 1.431 |
| March 26, 2024 | 1.400 |
| March 25, 2024 | 1.405 |
| March 22, 2024 | 1.445 |
| March 21, 2024 | 1.501 |
| March 20, 2024 | 1.480 |
| March 19, 2024 | 1.449 |
| March 18, 2024 | 1.456 |
| March 15, 2024 | 1.501 |
| March 14, 2024 | 1.489 |
| March 13, 2024 | 1.549 |
| March 12, 2024 | 1.530 |
| March 11, 2024 | 1.592 |
| March 08, 2024 | 1.661 |
| March 07, 2024 | 1.606 |
| March 06, 2024 | 1.588 |
| March 05, 2024 | 1.596 |
| March 04, 2024 | 1.637 |
| March 01, 2024 | 1.643 |
| February 29, 2024 | 1.615 |
| February 28, 2024 | 1.695 |
| February 27, 2024 | 1.707 |
| February 26, 2024 | 1.701 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.004
Minimum
May 09 2022
8.128
Maximum
Jul 12 2019
2.755
Average
2.013
Median
Mar 25 2021
Price to Book Value Benchmarks
| Biogen Inc | 2.082 |
| Perspective Therapeutics Inc | 14.13 |
| Vanda Pharmaceuticals Inc | 0.5153 |
| Ligand Pharmaceuticals Inc | 1.867 |
| ADMA Biologics Inc | 11.49 |
Price to Book Value Related Metrics
| PS Ratio | 9.177 |
| Price | 13.94 |
| Earnings Yield | -60.19% |
| Market Cap | 838.94M |